These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 2082485

  • 1. Dipyridamole combined with anticoagulant in prevention of early postoperative thromboembolism after cardiac valve replacement.
    Kawazoe K, Fujita T, Manabe H.
    Thromb Res Suppl; 1990; 12():27-33. PubMed ID: 2082485
    [Abstract] [Full Text] [Related]

  • 2. Trial of combined warfarin plus dipyridamole or aspirin therapy in prosthetic heart valve replacement: danger of aspirin compared with dipyridamole.
    Chesebro JH, Fuster V, Elveback LR, McGoon DC, Pluth JR, Puga FJ, Wallace RB, Danielson GK, Orszulak TA, Piehler JM, Schaff HV.
    Am J Cardiol; 1983 May 15; 51(9):1537-41. PubMed ID: 6342354
    [Abstract] [Full Text] [Related]

  • 3. Dipyridamole-aspirin as thromboembolic prophylaxis in patients with aortic valve prosthesis. Prospective study with the Model 2320 Starr-Edwards prosthesis.
    Brott WH, Zajtchuk R, Bowen TE, Davia J, Green DC.
    J Thorac Cardiovasc Surg; 1981 Apr 15; 81(4):632-5. PubMed ID: 7206773
    [Abstract] [Full Text] [Related]

  • 4. [Dipyridamole and warfarin in patients with artificial heart valve prosthesis: double-blind tests].
    Ciavarella N, Antoncecchi S, D'Elia N.
    Cardiologia; 1985 Apr 15; 30(4):301-7. PubMed ID: 3914360
    [No Abstract] [Full Text] [Related]

  • 5. High risk of thromboemboli early after bioprosthetic cardiac valve replacement.
    Heras M, Chesebro JH, Fuster V, Penny WJ, Grill DE, Bailey KR, Danielson GK, Orszulak TA, Pluth JR, Puga FJ.
    J Am Coll Cardiol; 1995 Apr 15; 25(5):1111-9. PubMed ID: 7897124
    [Abstract] [Full Text] [Related]

  • 6. Warfarin versus dipyridamole-aspirin and pentoxifylline-aspirin for the prevention of prosthetic heart valve thromboembolism: a prospective randomized clinical trial.
    Mok CK, Boey J, Wang R, Chan TK, Cheung KL, Lee PK, Chow J, Ng RP, Tse TF.
    Circulation; 1985 Nov 15; 72(5):1059-63. PubMed ID: 3899404
    [Abstract] [Full Text] [Related]

  • 7. Pharmacologic control of thromboembolic complications of cardiac-valve replacement.
    Sullivan JM, Harken DE, Gorlin R.
    N Engl J Med; 1971 Jun 24; 284(25):1391-4. PubMed ID: 4931099
    [No Abstract] [Full Text] [Related]

  • 8. Standard versus low-level anticoagulation combined to low-dose dipyridamole after mitral valve replacement.
    Hassouna A, Allam H, Awad A, Hassaballah F.
    Cardiovasc Surg; 2000 Oct 24; 8(6):491-8. PubMed ID: 10996106
    [Abstract] [Full Text] [Related]

  • 9. Antiplatelet drugs and the incidence of thromboembolic complications of the St. Jude Medical aortic prosthesis in patients with rheumatic heart disease.
    Ribeiro PA, Al Zaibag M, Idris M, Al Kasab S, Davies G, Mashat E, Wareham E, Al Fagih M.
    J Thorac Cardiovasc Surg; 1986 Jan 24; 91(1):92-8. PubMed ID: 3941564
    [Abstract] [Full Text] [Related]

  • 10. Anticoagulation therapy in children with mechanical prosthetic cardiac valves.
    Bradley LM, Midgley FM, Watson DC, Getson PR, Scott LP.
    Am J Cardiol; 1985 Sep 15; 56(8):533-5. PubMed ID: 4036839
    [Abstract] [Full Text] [Related]

  • 11. Anticoagulants and the Björk-Shiley prosthesis. Experience of 390 patients.
    Sutton MG, Miller GA, Oldershaw PJ, Paneth M.
    Br Heart J; 1978 May 15; 40(5):558-62. PubMed ID: 656224
    [Abstract] [Full Text] [Related]

  • 12. Frequency of prosthetic valve-related complications with very low level warfarin anticoagulation combined with dipyridamole after valve replacement using St. Jude Medical prostheses.
    Skudicky D, Essop MR, Wisenbaugh T, Skoularigis J, Essop AR, Dullabh A, Bedhesi S, Strugo V, Sareli P.
    Am J Cardiol; 1994 Dec 01; 74(11):1137-41. PubMed ID: 7977074
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Anticoagulant therapy in children with prosthetic valves.
    Rao PS, Solymar L, Mardini MK, Fawzy ME, Guinn G.
    Ann Thorac Surg; 1989 Apr 01; 47(4):589-92. PubMed ID: 2712632
    [Abstract] [Full Text] [Related]

  • 16. Antithromboembolic treatment after cardiac valve replacement.
    Kudoh T.
    Jpn Circ J; 1984 Oct 01; 48(10):1169-71. PubMed ID: 6492383
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Low-dose oral anticoagulation and antiplatelet therapy with St. Jude Medical heart valve prosthesis.
    Yamak B, Iscan Z, Mavitas B, Ulus AT, Katircioglu SF, Tasdemir O, Bayazit K.
    J Heart Valve Dis; 1999 Nov 01; 8(6):665-73. PubMed ID: 10616246
    [Abstract] [Full Text] [Related]

  • 20. Platelet survival time following aortic valve replacement.
    Steele P, Weily H, Davies H, Ppppas G, Genton E.
    Circulation; 1975 Feb 01; 51(2):358-62. PubMed ID: 1112016
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.